146 related articles for article (PubMed ID: 25055060)
1. Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.
Verdoia M; Schaffer A; Barbieri L; Sinigaglia F; Marino P; Suryapranata H; De Luca G;
Atherosclerosis; 2014 Sep; 236(1):169-74. PubMed ID: 25055060
[TBL] [Abstract][Full Text] [Related]
2. Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients.
Verdoia M; Schaffer A; Barbieri L; Di Giovine G; Marino P; Suryapranata H; De Luca G;
J Diabetes Complications; 2015; 29(4):517-22. PubMed ID: 25736187
[TBL] [Abstract][Full Text] [Related]
3. Platelet-larger cell ratio and the risk of periprocedural myocardial infarction after percutaneous coronary revascularization.
Verdoia M; Barbieri L; Schaffer A; Cassetti E; Marino P; Bellomo G; Sinigaglia F; De Luca G;
Heart Vessels; 2015 Jan; 30(1):20-7. PubMed ID: 24297745
[TBL] [Abstract][Full Text] [Related]
4. Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
Verdoia M; Barbieri L; Schaffer A; Cassetti E; Di Giovine G; Bellomo G; Marino P; Sinigaglia F; De Luca G
J Thromb Thrombolysis; 2014 Apr; 37(3):345-52. PubMed ID: 23793523
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine and risk of periprocedural myocardial infarction in patients undergoing coronary stenting.
Verdoia M; Schaffer A; Barbieri L; Cassetti E; Di Giovine G; Marino P; De Luca G;
J Cardiovasc Med (Hagerstown); 2015 Feb; 16(2):100-5. PubMed ID: 24625566
[TBL] [Abstract][Full Text] [Related]
6. Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
Verdoia M; Schaffer A; Barbieri L; Di Giovine G; Marino P; De Luca G;
Diabetes Metab Res Rev; 2014 May; 30(4):297-304. PubMed ID: 24829966
[TBL] [Abstract][Full Text] [Related]
7. Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban.
Verdoia M; Pergolini P; Barbieri L; Rolla R; Nardin M; Negro F; Suryapranata H; De Luca G;
Thromb Res; 2018 Apr; 164():17-23. PubMed ID: 29475177
[TBL] [Abstract][Full Text] [Related]
8. Effect of diabetes mellitus on periprocedural myocardial infarction in patients undergoing coronary stent implantation.
Verdoia M; Barbieri L; Schaffer A; Cassetti E; Di Giovine G; Nardin M; Bellomo G; Marino P; De Luca G;
Diabetes Metab Res Rev; 2015 Jan; 31(1):85-92. PubMed ID: 24898423
[TBL] [Abstract][Full Text] [Related]
9. Impact of the Polymorphism rs5751876 of the Purinergic Receptor ADORA2A on Periprocedural Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention.
Negro F; Verdoia M; Nardin M; Suryapranata H; Kedhi E; Dudek D; De Luca G;
J Atheroscler Thromb; 2021 Feb; 28(2):137-145. PubMed ID: 33342966
[TBL] [Abstract][Full Text] [Related]
10. Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty.
Verdoia M; Camaro C; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G
Atherosclerosis; 2013 May; 228(1):136-41. PubMed ID: 23518179
[TBL] [Abstract][Full Text] [Related]
11. Non-HDL cholesterol is a better target for predicting periprocedural myocardial injury following percutaneous coronary intervention in type 2 diabetes.
Zeng RX; Li XL; Zhang MZ; Guo YL; Zhu CG; Guo LH; Li S; Zhang Y; Li JJ
Atherosclerosis; 2014 Dec; 237(2):536-43. PubMed ID: 25463086
[TBL] [Abstract][Full Text] [Related]
12. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
Niccoli G; Sgueglia GA; Latib A; Crea F; Colombo A;
Catheter Cardiovasc Interv; 2014 Jan; 83(1):E37-44. PubMed ID: 23813627
[TBL] [Abstract][Full Text] [Related]
13. Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
Ben-Yehuda O; Chen S; Redfors B; McAndrew T; Crowley A; Kosmidou I; Kandzari DE; Puskas JD; Morice MC; Taggart DP; Leon MB; Lembo NJ; Brown WM; Simonton CA; Dressler O; Kappetein AP; Sabik JF; Serruys PW; Stone GW
Eur Heart J; 2019 Jun; 40(24):1930-1941. PubMed ID: 30919909
[TBL] [Abstract][Full Text] [Related]
14. Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation.
Verdoia M; Schaffer A; Barbieri L; Di Giovine G; Bellomo G; Marino P; Suryapranata H; De Luca G
Neth Heart J; 2016 Jul; 24(7-8):462-74. PubMed ID: 27277659
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D deficiency and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.
Verdoia M; Ceccon C; Nardin M; Suryapranata H; De Luca G;
Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):744-750. PubMed ID: 29656938
[TBL] [Abstract][Full Text] [Related]
16. Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study.
Verdoia M; Schaffer A; Cassetti E; Di Giovine G; Marino P; Suryapranata H; De Luca G
J Thromb Thrombolysis; 2015 May; 39(4):459-66. PubMed ID: 25079972
[TBL] [Abstract][Full Text] [Related]
17. Remnant cholesterol predicts periprocedural myocardial injury following percutaneous coronary intervention in poorly-controlled type 2 diabetes.
Zeng RX; Li S; Zhang MZ; Li XL; Zhu CG; Guo YL; Zhang Y; Li JJ
J Cardiol; 2017 Aug; 70(2):113-120. PubMed ID: 28209463
[TBL] [Abstract][Full Text] [Related]
18. Relationship of non-cardiac biomarkers with periprocedural myocardial injury in patients undergoing percutaneous coronary intervention.
Zeng RX; Li JJ; Liao PD; Zhang MZ
Int J Cardiol; 2016 Oct; 221():726-33. PubMed ID: 27428312
[TBL] [Abstract][Full Text] [Related]
19. MTHFR polymorphism and risk of periprocedural myocardial infarction after coronary stenting.
Verdoia M; Schaffer A; Cassetti E; Barbieri L; Di Giovine G; Marino P; De Luca G;
Nutr Metab Cardiovasc Dis; 2014 May; 24(5):532-7. PubMed ID: 24418373
[TBL] [Abstract][Full Text] [Related]
20. Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI.
Verdoia M; Secco GG; Barbieri L; Cassetti E; Schaffer A; Sinigaglia F; Marino P; Suryapranata H; De Luca G;
Platelets; 2014; 25(5):367-72. PubMed ID: 24283589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
